124 related articles for article (PubMed ID: 28948184)
1. Acute Liver Failure Due to Echovirus 9 Associated With Persistent B-Cell Depletion From Rituximab.
Bajema KL; Simonson PD; Greninger AL; Çoruh B; Pottinger PS; Bhattacharya R; Liou IW; Jalikis FG; Fligner CL; Rakita RM
Open Forum Infect Dis; 2017; 4(3):ofx174. PubMed ID: 28948184
[TBL] [Abstract][Full Text] [Related]
2. Use of intravenous immunoglobulin to treat chronic bilateral otomastoiditis in the setting of rituximab induced hypogammaglobulinemia.
Otremba MD; Adam SI; Price CC; Hohuan D; Kveton JF
Am J Otolaryngol; 2012; 33(5):619-22. PubMed ID: 22361345
[TBL] [Abstract][Full Text] [Related]
3. Consequences of B-cell-depleting therapy: hypogammaglobulinemia and impaired B-cell reconstitution.
Sacco KA; Abraham RS
Immunotherapy; 2018 Jun; 10(8):713-728. PubMed ID: 29569510
[TBL] [Abstract][Full Text] [Related]
4. [Rituximab and hypogammaglobulinemia].
Fernández Romero DS; Torre MG; Larrauri BJ; Malbrán E; Juri MC; Malbrán A
Medicina (B Aires); 2015; 75(5):319-23. PubMed ID: 26502469
[TBL] [Abstract][Full Text] [Related]
5. A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure.
Shen T; Lin BY; Jia JJ; Wang ZY; Wang L; Ling Q; Geng L; Yan S; Zheng SS
Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):395-401. PubMed ID: 25100124
[TBL] [Abstract][Full Text] [Related]
6. Suppression of normal immune responses after treatment with rituximab.
Kado R; Sanders G; McCune WJ
Curr Opin Rheumatol; 2016 May; 28(3):251-8. PubMed ID: 27027812
[TBL] [Abstract][Full Text] [Related]
7. Post-rituximab immunoglobulin M (IgM) hypogammaglobulinemia.
Kridin K; Ahmed AR
Autoimmun Rev; 2020 Mar; 19(3):102466. PubMed ID: 31917267
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and therapeutic considerations in patients with hypogammaglobulinemia after rituximab therapy.
Kado R; Sanders G; McCune WJ
Curr Opin Rheumatol; 2017 May; 29(3):228-233. PubMed ID: 28240614
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD20 monoclonal antibody (Rituximab) treatment for Epstein-Barr virus-associated, B-cell lymphoproliferative disease in pediatric liver transplant recipients.
Serinet MO; Jacquemin E; Habes D; Debray D; Fabre M; Bernard O
J Pediatr Gastroenterol Nutr; 2002 Apr; 34(4):389-93. PubMed ID: 11930095
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: a case series.
Roberts DM; Jones RB; Smith RM; Alberici F; Kumaratne DS; Burns S; Jayne DR
J Autoimmun; 2015 Feb; 57():24-9. PubMed ID: 25586449
[TBL] [Abstract][Full Text] [Related]
11. Rituximab and immune deficiency: case series and review of the literature.
Kaplan B; Kopyltsova Y; Khokhar A; Lam F; Bonagura V
J Allergy Clin Immunol Pract; 2014; 2(5):594-600. PubMed ID: 25213054
[TBL] [Abstract][Full Text] [Related]
12. Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases.
Khojah AM; Miller ML; Klein-Gitelman MS; Curran ML; Hans V; Pachman LM; Fuleihan RL
Pediatr Rheumatol Online J; 2019 Aug; 17(1):61. PubMed ID: 31462263
[TBL] [Abstract][Full Text] [Related]
13. Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia.
Barmettler S; Ong MS; Farmer JR; Choi H; Walter J
JAMA Netw Open; 2018 Nov; 1(7):e184169. PubMed ID: 30646343
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
15. Profound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literature.
Levy R; Mahévas M; Galicier L; Boutboul D; Moroch J; Loustau V; Guillaud C; Languille L; Fain O; Bierling P; Khellaf M; Michel M; Oksenhendler E; Godeau B
Autoimmun Rev; 2014 Oct; 13(10):1055-63. PubMed ID: 25183241
[TBL] [Abstract][Full Text] [Related]
16. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.
Olfat M; Silverman ED; Levy DM
Lupus; 2015 Aug; 24(9):966-72. PubMed ID: 25804672
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Responsiveness to Reduced-Dose Rituximab in Corticotropin/Intravenous Immunoglobulin/Rituximab Combination Immunotherapy for Opsoclonus-Myoclonus Syndrome.
Pranzatelli MR; Tate ED; McGee NR; MacArthur CA
Pediatr Neurol; 2018 Aug; 85():71-75. PubMed ID: 30197220
[TBL] [Abstract][Full Text] [Related]
18. Echovirus polymyositis in patients with hypogammaglobulinemia. Failure of high-dose intravenous gammaglobulin therapy and review of the literature.
Crennan JM; Van Scoy RE; McKenna CH; Smith TF
Am J Med; 1986 Jul; 81(1):35-42. PubMed ID: 3728553
[TBL] [Abstract][Full Text] [Related]
19. B-cell depletion for 2 years after autologous stem cell transplant for NHL induces prolonged hypogammaglobulinemia beyond the rituximab maintenance period.
Lim SH; Esler WV; Zhang Y; Zhang J; Periman PO; Burris C; Townsend M
Leuk Lymphoma; 2008 Jan; 49(1):152-3. PubMed ID: 18203024
[No Abstract] [Full Text] [Related]
20. [Infections of the central nervous system caused by enterovirus: 223 cases seen at a pediatric hospital between 1973 and 1981].
Thivierge B; Delage G
Can Med Assoc J; 1982 Dec; 127(11):1097-102. PubMed ID: 6291736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
